Analystreport

Unity Biotechnology, Inc. (NASDAQ: UBX) had its price target raised by analysts at Wedbush from $4.00 to $36.00.

Unity Biotechnology, Inc.  (UBX) 
Last unity biotechnology, inc. earnings: 3/11 04:05 pm Check Earnings Report